T-Cell Prolymphocytic Leukemia — Trials

T-Cell Prolymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: Ascentage Pharma Group Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05823571	Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients	active not recruiting	Phase 1	32	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Sep 18, 2025	clinicaltrials

Data updated 22 days agoSource updated Sep 18, 2025source: clinicaltrials